Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Advocate for proposals to provide direct financial support to safety net hospitals with Congressional staff.
Discuss support for the 340B Drug Pricing Program with Congressional staff and discuss certain changes: oppose 340B ACCESS Act (H.R. 7635), comment on SUSTAIN 340B Act discussion draft, support PATIENTS Act (H.R. 7635).
Discuss legislative proposals with Congressional staff to stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support); make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities.
Discuss Medicare Graduate Medical Education (GME) provisions in the Consolidated Appropriations Act (CAA), 2021 and CAA, 2023 with HHS staff.
Discuss with Congressional staff support for Medicare GME expansion: the Resident Physician Shortage Reduction Act, the Pathway to Practice Act of 2021, the Substance Use Disorder Workforce Act (H.R. 7050); additional GME slots in CAA, 2021 and CAA, 2023; Rural Residency Planning and Development Act (H.R. 7855).
Oppose Rural Physician Workforce Preservation Act (H.R. 8235) and modifications to ongoing distribution of CAA, 2021 Section 126 GME slots.
Discuss with HHS staff and Congressional staff recommendations to address workforce shortages for nursing and ancillary health care workforce with Congressional staff: faculty recruitment and retention, additional financial support for supervision and precepting students, Medicare payment for nursing and allied health, testing new workforce models, establishing incentives and early recruitment strategies, providing funding for clinical training site, and immigration reforms that expedite entry for foreign health care workers.
Support passage of the Safety from Violence for Healthcare Employees (SAVE) Act (H.R. 2584/S.2768).
Support revisions to Conrad 30 waiver program to increase the number of foreign physicians that may remain in the US after completing GME: S.665/H.R.4942, S.2719/H.R.6980, H.R. 4875.
Meet with Congressional staff to discuss technical amendment to CAA, 2021, Section 131.
Respond to Senate Finance Committee request for information on Medicare GME and offer recommendations.
Discuss opposition to site-neutral payment policies with Congressional staff.
Educate Congressional staff on hospital price transparency federal rule (84 FR 65602).
Meet with Congressional staff to discuss H.R. 5378, the Lower Costs, More Transparency Act of 2023, and comment on following proposals in bill: support for delay of Medicaid DSH cut, codification and expansion of Federal price transparency rule, oppose National Provider Identifier (NPI) requirements for hospital outpatient departments, oppose changes to 340B drug pricing program, support reauthorization of Community Health Centers, support reauthorization of National Health Service Corps, support reauthorization of Teaching Health Center Graduate Medical Education funding.
Oppose Medicare site-neutral cuts, Medicare sequester cuts, and NPI proposals in H.R. 4822.
Oppose changes to NPIs for hospital outpatient departments (H.R. 7623, H.R. 4509, H.R. 7623 as amended).
Comment on legislative proposals in S.2840, the Primary Care and Health Workforce Expansion Act: oppose eliminating facility fees, oppose requiring a separate identification number for off-campus hospital outpatient departments.
Discuss S.3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, with Congressional staff.
Discuss hospital and health provisions in CAA, 2024 (H.R. 4366) with HHS staff.
Discuss expiring COVID-19 Public Health Emergency Medicare flexibilities with Congressional staff and HHS staff and support legislative proposals to extend PHE telehealth flexibilities and Acute Hospital Care at Home Waiver: H.R. 7623.
Support public health extenders and elimination of Medicaid DSH cut in CAA, 2024 (H.R. 4366).
Meet with Congressional staff to discuss proposals for financial relief for hospitals affected by the Change Healthcare cyberattack.
Oppose legislative proposals to impose financial penalties on hospitals relating to minimum cybersecurity standards (S.5218).
Discuss legislative proposals to regulate the use of artificial intelligence in health care delivery with Congressional staff.
Support S.5026, SEPSIS Act.
Discuss FEMA COVID-19 Public Assistance payouts with Congressional staff.
Discuss FDA final rule to regulate laboratory developed tests (89 FR 37286) with Congressional staff.
Support passage of Improving Seniors Timely Access to Care Act (S. 4532/H.R. 8702).
Discuss legislative proposals on consumer medical debt with Congressional staff.
Discuss life safety building code requirements with HHS.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Federal Emergency Management Agency (FEMA), Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Discuss Medicare and Medicaid issues with HHS staff.
Discuss with Congressional staff and HHS staff support for Medicare GME expansion: the Resident Physician Shortage Reduction Act, the Pathway to Practice Act of 2021, the Substance Use Disorder Workforce Act; additional GME slots in CAA, 2021 and CAA, 2023; Rural Residency Planning and Development Act (H.R. 7855).
Discussion with CMS on the interpretation of CAA, 2021, Sec. 131, and resetting of GME caps pertaining to Sec. 131.
Discuss technical amendment to CAA, 2021, Sec. 131 pertaining to Medicare GME with Congressional staff.
Discuss with Congressional staff distribution methodology for Medicare GME slots created in the CAA, 2021.
Discuss expiring COVID-19 Public Health Emergency (PHE) Medicare flexibilities with Congressional staff and HHS staff and support legislative proposals to extend PHE telehealth flexibilities and Acute Hospital Care at Home Waiver (H.R. 7623).
Discuss legislation to provide financial support for safety net hospitals.
Discuss opposition to Medicare site-neutral payment policies with Congressional staff.
Support certain changes to Medicaid DSH: support two year elimination of Medicaid DSH cut scheduled for January 1, 2025; support Save Our Safety Net Hospitals Act (H.R. 9351) to restore pre-CAA, 2021 DSH cap calculation methodology and include dual-eligible patients in state DSH cap calculation.
Discuss Medicaid waiver proposal with Congressional staff and HHS.
Discuss CMMI initiatives on global budgets and primary care in NYS Medicaid waiver.
Discuss Medicaid IMD exclusion policies with Congressional staff.
Support legislation to increase Medicaid payment rates for labor and delivery services for certain hospitals (S.5236).
Discuss with Congressional staff support for CMS approval of Medicaid managed care organization tax proposed in New York State budget.
Discuss comments on FY 2024 IPPS proposed rule to increase payment update to hospitals, Transforming Episodic Accountability Model, AHEAD Model, and CAA, 2023 Sec 4122 GME slot proposed distribution methodology and discuss comments with Congressional staff and CMS staff.
Discuss Medicare payment for nursing and allied health with Senate Finance Committee staff.
Meet with CMS Regional Administrator to discuss the behavioral health care workforce.
Meet with CMS to discuss hospital price transparency regulations.
Discuss proposals that stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support), make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities.
Oppose CMS final rule to establish minimum nurse staffing in Medicare- and Medicaid-certified long-term care facilities (89 FR 40876) and support legislative efforts to repeal rule.
Meet with CMS staff to discuss behavioral health coverage for commercial insurers.
Discussion with HHS Health Insurance Administrator and CMS Hospital Quality, Safety, and Oversight Group on CMS Interpretive Guidance on Informed Consent.
Support Medicare Advantage prior authorization reforms.
Meet with CMS staff and CMS Regional Administrator to discuss Medicare Advantage (MA) plans and MA utilization management practices.
Discuss wage index issues with Congressional staff: H.R. 8561 to address MA local area growth under projection, FY 2025 IPPS/LTCH interim final rule, indirect medical education (IME) payments to hospitals.
Meet with CMS Innovation Center to discuss CMMI models of care.
Meet with CMS leadership to discuss Medicare and Medicaid issues: prior authorization and MA insurance denials, concerns on mandatory participation for AHEAD and TEAM models, Medicare support for health care workforce; support for telehealth flexibilities and Acute Hospital Care at Home waiver extension.
Meet with CMS/Acute Care regarding the definition of new residency programs.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Discuss Medicare GME funding in CAA, 2021 and CAA, 2023 with Congressional staff and HHS staff.
Discuss Medicare Nursing and Allied Health Education Payment Policies in CAA, 2023 Section 4143 Implementation with House Ways and Means staff.
Meeting with House Ways and Means Committee staff to discuss safety net hospital funding issues and payments for safety net hospitals.
Meeting with CMS Regional Administration to discuss safety net funding issues.
Discuss health and hospital provisions in CAA, 2024 (H.R. 4366) and Further Consolidated Appropriations Act, 2024 (H.R. 2882).
Support supplemental disaster funding for FEMA in Continuing Appropriations and Extension Act, 2025 (H.R. 9747).

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Federal Emergency Management Agency (FEMA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes